The dose escalation, published
Above a stated dose, the site says the price is prone to increase by a fixed amount per month, and it gives a different amount for each molecule. That is the charge most sellers here leave a buyer to discover in month four.
It is a qualified statement — prone to increase, not will — but it is a number, on the seller’s own page, attached to a threshold. Nothing else in this sweep except one clinic publishes anything comparable.
An opening rate and a reversion, both printed
Each molecule has a first-month figure with the rate that follows it in the same sentence, and a three-month bundle whose total the seller then averages out per month itself. One of those bundles is also expressed per day.
Its oral-drops page carries the standard injection block and no figure of its own, so what the drops cost is not published. We have recorded that rather than assuming the drops match the injection.
A named pharmacy, and a company with three names
It names the compounding pharmacy, which is rare here, and states a fifty-state prescriber licence in several places with a service-area page of its own.
Its footer and its privacy policy carry two different corporate forms for the operator, and FDA’s letter names a third. Its terms name two separate partner agencies for the clinical side.
One instrument note worth recording: a path that does not exist on this host returns a server error rather than a not-found, which makes any absence of a page here a weaker signal than on a host that 404s honestly.
Biopreventative's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $197/mo"One Month Starter $297 $197/ first month · Save $100 · After your first month your payment will be $297/month*" | September 2026source |
| Semaglutide (compounded) | $297/mothe rate that follows the opening month, in the seller's own words: "After your first month your payment will be $297/month*". ⛔ The asterisk matters: above a stated dose the page says the price "will be prone to increase by $100 per month" | September 2026source |
| Semaglutide (compounded) | $699a three-month total: "Three Month Starter $899 $699 / THREE MONTHS · Save $200 · Your 3 month bundle will average out to $233/month over the course of 3 months" | September 2026source |
| Tirzepatide (compounded) | $349/mo"One Month Starter $449 $349/ first month · Save $100 · After your first month your payment will be $449/month*" | September 2026source |
| Tirzepatide (compounded) | $449/mothe rate after the opening month. ⛔ Above a stated dose the same site says the tirzepatide price "will be prone to increase by $200 per month" | September 2026source |
| Tirzepatide (compounded) | $897a three-month total the seller also expresses per day: "$897 / per 3 month · $9.97 / DAY", and elsewhere as "$1347 $897 / THREE MONTHS · Save $450 · Your 3 month bundle will average out to $299/month" | September 2026source |
| Semaglutide (compounded-oral) | $197/mo⚠ The oral-drops page carries the site's standard semaglutide block — "Semaglutide Weight Loss Prescribed Online $297 $197" — and no figure of its own for the drops. The drops are recorded at the injection's price only because that is the sole figure the drops page prints | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 240 providers reviewed here are paid partners today; the other 236 are not. See how this works.
See Biopreventative's current price →Good fit if
- Buyers who want the price rise at a higher dose stated before they start.
- Readers who want the reversion rate printed beside the opening one.
- People who want the compounding pharmacy named.
Look elsewhere if
- Anyone who wants the headline figure to be the ongoing one.
- Readers who want the oral drops priced.
- Buyers who want one corporate name rather than three.
- People who need a named prescribing clinician.
How this review was verified
- Re-read both drug pages, the oral-drops page, the privacy policy and the terms on 7 September 2026, comparing requested to effective URLs with a nonsense path against the host in the same run.
- Recorded that the nonsense path returned a server error rather than a not-found, and treated absences on this host as weaker evidence accordingly.
- Recorded the dose-escalation charge as the seller states it, including the qualification that it is prone to rather than certain.
- Recorded that the oral-drops page carries no figure of its own rather than attaching the injection’s price to it.
- Screened the operating company against FDA’s live warning-letter datatable with both controls green, then re-fetched the letter: 200, title matching the company, the reference number and the date, against a minted nonsense letter path returning 404 in the same run.